Epithelial and endothelial cells expressing the primary Coxsackie virus B adenovirus (Ad) receptor (CAR) and integrin coreceptors are natural targets of human Ad infections. The fiber knob of species A, C, D, E and F Ad serotypes binds CAR by mimicking the CAR-homodimer interface, and the penton base containing arginine-glycineaspartate (RGD) motifs binds with low affinity to av integrins inducing cell activation. Here, we generated seven different genetically modified Ad vectors with RGD sequences inserted into the HI loop of fiber knob. All mutants bound and infected CAR and av integrin-positive epithelial cells with equal efficiencies. However, the Ads containing two additional cysteines, both N and C terminals of the RGD sequence (RGD-4C), were uniquely capable of transducing CAR-less hematopoietic and nonhematopoietic human tumor cell lines and primary melanoma cells. Both binding and transduction of RGD-4C Ad were blocked by soluble RGD peptides. Flow cytometry of cell surface integrins and virus binding to CAR-less cells in the presence of function-blocking anti-integrin antibodies indicated that the avb5 integrin, but not avb3, aIIbb3 or b1,a5 or a6-containing integrins served as a functional transduction receptor of the RGD-4C Ads. However, in cells with low levels of avb5 integrin, the function-blocking anti-avb5 antibodies were not effective, unlike soluble RGD peptides. Collectively, our data demonstrate that the avb5 integrin is a functional transduction receptor of RGD-4C Ads in the absence of CAR, and that additional RGD receptors are targets of these viruses. The RGD-4C vectors further extend the tropism of Ads towards potential human therapies.
Introduction
Human adenoviruses (Ads) infect numerous tissues and cell lines with excellent efficiencies. Accordingly, replication-defective Ad vectors carrying therapeutic genes have been employed for a wide variety of gene therapy applications 1 and conditionally replicating Ads are being developed for cancer treatments. 2 In human epithelial and other permissive cells, efficient entry of the species C Ads, including the currently used Ad2 and Ad5, depends on the presence of the Coxsackie virus B Ad receptor (CAR) 3, 4 and of secondary integrin coreceptors. 5, 6 Integrin binding of the conserved arginineglycine-aspartate (RGD) motif of the capsid protein penton base activates virus uptake by receptor-mediated endocytosis using clathrin-coated pits. [7] [8] [9] Although there are at least eight different cell surface integrins recognizing RGD, including the five av integrins avb1, avb3, avb5, avb6, avb8, and the aIIbb3, a3b1 and a5b1 integrins, 10 only avb3 and avb5, 5 a5b1 11 and avb1 12, 13 have been implicated as Ad secondary receptors.
Both primary and secondary Ad receptors are required for efficient infections of different types of cells, such as polarized airway epithelial cells, [14] [15] [16] [17] brain tissue, 18 skeletal muscle, 19, 20 endothelial and smooth muscle cells, 21 and certain hematopoietic cells including human leukocytes [22] [23] [24] and human monocyte-derived dendritic cells (DCs). [25] [26] [27] However, the expression levels of CAR were found to vary considerably among tumors of different origins, including hematopoietic malignancies, [28] [29] [30] [31] [32] melanoma cell cultures, 33 bladder cancer cells, 34 head and neck cancer 35 and ovarian tumors. 36 To overcome a limited expression of natural Ad receptors, host-range modifications of potentially therapeutic vectors have been proposed (for a review see Krasnykh et al 37 ) . One promising approach to expand the viral tropism is to incorporate targeting ligands genetically into capsid proteins, such as the fiber knob, the penton base, hexon or the stabilizing protein IX, as described recently. 38 Targeting ligands included the integrin-binding RGD motif flanked on both sides by cysteine-aspartate/phenylalanine-cysteine residues (RGD-4C), 39 which had been inserted either together with a 10-amino-acid linker at the carboxy terminus of the Ad5 fiber 40 or into the fiber HI loop. 41 A similar RGD sequence was also introduced into a hypervariable region of the Ad5 hexon and this conferred a fiber knob-independent transduction of epithelial cells. 42 This all suggests that the ablation of the native viral tropism and true retargeting may be feasible. Precise knowledge of the transduction pathway is required for transferring any modified viral vector into the clinic. Given that the RGD-dependent entry of natural species C Ad vectors is rather well characterized in terms of viral endocytosis and cell activation (for recent reviews, see 43, 44 ), we decided to generate a panel of fiber-HI loop-modified Ads by genetic insertions of RGD sequences. All viruses infected CAR-and avb5-positive cells equally well, but only the Ads bearing the constrained RGD-4C motif transduced CAR-negative cells in an RGD-dependent manner. Our data indicate that RGD-4C inserted into the HI loop targets avb5 integrin and thereby effectively transduces cells lacking the primary receptor CAR.
Materials and methods

Cell culture
Jurkat (acute T-cell leukemia), U937 (D) and (H) (monocytic lymphoma, different sublines), Daudi, Ramos and Raji (Burkitt's B-lymphoma) and K562 (chronic myelogenous leukemia) cells were grown in RPMI 1640 plus 10% fetal calf serum (FCS). HL-60 (promyelocytic leukemia) and THP-1 (acute monocytic leukemia) cells were cultured in Iscove-modified Dulbecco medium (IMDM) plus 10% FCS, as described. 45 The human embryonic retinoblast cell line 911 cells was received from Fallaux et al 46 and grown in Dulbecco's modified Eagle's medium (DMEM) plus 10% FCS. The primary melanoma short-time cultures M950822, M951004, M950504, M961205, M960104 and M950710 were obtained from R Dummer (Department of Dermatology, University of Zü rich) and were grown in DMEM plus 10% FCS. 47 The human embryonal rhabdomyosarcoma (RD) cell line was obtained from R Eckner (Institute of Molecular Biology, University of Zü rich). Freshly isolated, primary human umbilical vein endothelial cells (HUVEC) were a kind gift of L Jornot (Respiratory Division, University Hospital Genève, Genève, Switzerland) and were grown in RPMI 1640 plus 10% FCS, 15 mg/ml endothelial cell growth supplement, 90 mg/ml heparin, and 25 mM HEPES (pH 7.0). Primary human fibroblasts isolated from human foreskin were kindly provided by J Liu (Department of Dermatology, University Hospital, Zü rich, Switzerland). The A549 human lung carcinoma cell line was received from P Sonderegger (Biochemical Institute, University of Zü rich) and was grown in DMEM plus 10% FCS. All cell lines were routinely screened for the absence of mycoplasma contamination. Monocyte-derived DCs were generated as described previously. 48 Briefly, DCs were isolated from the buffy coat of blood samples taken from healthy donors and incubated for 7 days in the presence of interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF). To induce maturation, a cocktail containing IL-4, GM-CSF, IL-1b, IL-6 and tumor necrosis factor a was added at day 7. Such cultures consisted of approximately 95% mature, loosely adherent DCs positive for CD83 surface expression.
Construction of recombinant fiber-modified Ad
The AdCMV-eGFP vectors containing modified fibers (D-K) or wild-type (wt) fiber (Z) are listed in Table 1 . They were constructed in two steps. In the first step, the fiber modifications were introduced into AdMLP-lacZ, an E1/E3 deletion mutant derived from Ad5dl324 containing the b-galactosidase gene in the E1 region under the control of the Ad mayor late promoter (MLP). This was accomplished using either a homologous recombination in 911 helper cells (for AdCMV-eGFP-D) 49 or a ligation (AdCMV-eGFP E-K and Z). 50 As the eGFP reporter turned out to be more convenient for transgene expression analysis, homologous recombination in 911 cells was used to exchange the MLP-lacZ reporter system with the CMV-eGFP transgene in all of the eight constructs.
Thus, the modifications of the fiber gene (positions 31 168-32 910) were introduced into AdMLP-lacZ making use of a transfer plasmid pAdMlu-frg, containing the Ad5 MluI right-end 9737 bp fragment including the whole open reading frame of the fiber gene (1743 bp The AdMLP-lacZ-D virus was generated by homologous recombination in 911 helper cells after transfecting the SpeI-restricted viral genomic AdMLP-lacZ DNA (lacking 7047 bp of the right end) together with the linearized pAdMlu-frg-D. The region of homologous sequence encompasses 2690 bp. The residual six fibermutated AdMLP-lacZ-E, -F, -G, -H, -I and -K were generated by ligation of the SpeI-restricted viral genomic AdMLP-lacZ DNA with the SpeI-restricted pAdMlu-frg-E, -F, -G, -H, -I and -K, respectively. Exchange of the reporter system was accomplished using the left-end transfer plasmid pAdCMV-eGFP derived from pEGFP-N1 (Clontech, Palo Alto, USA) and ClaI-restricted viral DNA. CsCl purification and determination of viral titers were performed as described previously. 33 Viral DNAs from all the seven constructs were purified and resequenced to confirm HI-loop alterations.
Immunoreagents and flow cytometric analysis Table 2 lists references and sources of the antibodies used for the characterization of integrins.
For cytofluorometric analysis of adherent cells, subconfluent cells were washed with PBS and detached by treatment with PBS-20 mM EDTA. Approximately 10 6 cells were incubated with either 50 ml of hybridoma supernatant or 1 mg of various antigen-specific antibodies in 250 ml of balanced salt solution (BSS) (0.14 M NaCl, 1 mM CaCl 2 , 5.4 mM KCl, 0.8 mM MgSO 4 , 0.3 mM NaH 2 PO 4 , and 0.4 mM KH 2 PO 4 pH 6.9) containing 5% FCS on ice for 30 min. If unlabelled primary antibodies were used, cells were washed by pelleting in BSS-2% FCS, incubated with 1 mg of phycoerythrinlabelled secondary conjugates and washed again before cytofluorometric analysis (Epics XL; Coulter, Miami, USA) was performed with 10 000 viable cells per sample.
For eGFP expression analysis, cells were infected with fiber-modified and unmodified Ads containing the eGFP reporter at multiplicities of infection (MOI) of 0.1, 1, 10 and 100. At 2 days postinfection, cells were detached, washed and analyzed as described above. The GRGDSP peptide and the GRGESP control peptide (5 mM each, Biochemical Institute, University of Zü rich, Switzerland) were added to the cells prior to adding the reporter virus. S-label (ICN Biomedicals, Irvine, USA) in 15 ml for 24 h, when the medium was supplemented with an equal volume of complete medium for an additional 20 h. Viruses were released from cells by three cycles of freeze-thaw and extraction with Freon 113 (Chemie Brunschwig, Switzerland) and purified by two subsequent centrifugations through two cushions of 1.2 and 1.45 g/ml CsCl in 50 mM Tris-HCl (pH 8.0) as described. 51 Viruses were dialyzed against PBS and stored in aliquots at À801C. Specific infectivity was determined to be 0.4 Â 10 À3 cpm/PFU for AdCMVeGFP-E and AdCMV-eGFP-Z, and 0.7 Â 10 À3 cpm/PFU for AdCMV-eGFP-K. The cells were washed three times by pelleting in binding buffer, dissolved in 1 ml 0.1% SDS, and the cell-associated radioactivity was determined by scintillation counting as described. 52 
Virus-binding assays
Results
Construction of fiber-modified RGD-Ads
To extend the Ad tropism, the integrin-binding RGD motif has been inserted into several viral capsid proteins, including the fiber HI-loop. 41 The most effective motif was a disulfide-restrained RGD-4C nonapeptide that was previously shown to bind with high affinity to both avb3 and avb5 integrins. 39 We speculated that the particular context in which the RGD motif is presented to integrins will also influence the binding and transduction. We therefore constructed a series of seven fiber-HI-loop-modified Ads by genetic insertion of sequences containing the integrin-binding peptide motif RGD, including the RGD-4C Ad vector (AdCMV-eGFP-K, AdK) described by others (Table 1) . 41 In the AdK construct, the RGD-4C peptide had been inserted into the HI loop, increasing the HI loop by seven amino acids. In contrast, the AdCMV-eGFP-E (AdE) construct contained the same peptide, but parts of the wt sequence were replaced, maintaining the HI loop length of 13 amino acids. In constructs AdCMV-eGFP-D (AdD), -F (AdF), -G (AdG), -H (AdH), and -I (AdI), the surrounding sequences of the linear RGD sequence motif were varied. The HI loop of AdD contained three and four amino acids flanking the RGD of the Ad5 penton base. In AdF, AdG and AdH, the RGD sequence was introduced either on the C-terminal, the central or N-terminal side of the HI loop, leaving the residual HI sequence unchanged. In AdI, all the three RGD motifs of AdF, AdG and AdH were introduced simultaneously. Construct AdCMV-eGFP-Z (AdZ) contained the wt fiber sequence. All constructs were first prepared to contain lacZ as a reporter gene and were later modified to contain the eGFP reporter gene for cytofluorometric expression assays. It was possible to rescue infectious viruses from all the constructs. The viral titers (PFU) were evaluated by standard plaque-formation assays on 911 cells and compared to the virus concentrations expressed as particles per ml ( Table 1 ). The infectivity index (PFU per particle) varied between 0.015 and 0.069, corresponding to a range of 67-14 particles per PFU. Of note is that the RGD-4C AdE had the highest specific activity of all viruses.
RGD-4C Ads efficiently transduce CAR-negative avb5-integrin-expressing cells
We first assessed the transduction potential of the RGDmodified Ad vectors on adherent epithelial A549 cells and primary HUVECs. These cells were CAR-positive and expressed high levels of surface avb5 over avb3 integrins (Table 3) , as determined by either cytofluorometric analysis or by Western blotting for CAR 45 and by cytofluorometric analysis using specific anti-integrin Integrin targets of RGD-4C fiber-modified adenoviruses H Nagel et al antibodies (Table 2) . Quantitative eGFP expression analyses indicated that both A549 and HUVECs were equally well transduced by the seven different Ad vectors, independent of whether they carried an extra RDG motif in their fiber knob (Figure 1 ). The same results were obtained with the CAR and av-integrinpositive rhabdosarcoma cells RD and the primary human melanoma cells M951004 (not shown). Likewise, eGFP expression by any of the RGD-modified Ads was very similar to control wt fiber virus in CAR-and av-integrinpositive hematopoietic cells, such as the leukemia K562, Raji and Jurkat cells (Table 4 , and not shown). This suggests that the affinity of the RGD-Ads to CAR is higher than for RGD-recognizing surface receptors. Also, for the hematopoietic cells, a much lower plateau level of maximal expression was obtained, when compared to nonhematopoietic cells. A different picture emerged when we analyzed the transduction of CAR-negative nonhematopoietic melanoma cells and primary fibroblasts (Figures 2 and 3 ). If these cells expressed high levels of avb5 integrin, they could be efficiently transduced by the RGD-4C Ads AdE and AdK, yielding enhancements of nearly two logs compared to the control AdZ. This was observed with primary fibroblasts (Figure 2a) , and a panel of different melanoma cells (Figures 2b-d and 3a) . The transduction boosts of the RGD-4C Ads strictly depended on the multiplicity of infection in the range of 1-100. M950710 cells which expressed low levels of avb5 integrin exhibited lowest transduction increase, with a maximal 27-fold. The transduction increases were blocked to 80% by soluble RGDpeptides, when compared to control RGE peptides, indicating specificity, as shown for the 
Table 4 Expression of CAR and integrins on hematopoietic cells and impact of RGD-Ads on transgene expression
Transduction (mean eGFP) at MOI 100
Up to 300-fold increase U937 (H) (monocytic lymphoma, alternative sub-line)
(chronic myelogenous leukemia)
No increase Jurkat (acute T-cell leukemia) Integrin targets of RGD-4C fiber-modified adenoviruses H Nagel et al M950504 melanoma cells (Figure 3b) . Note, however, that the RGE peptides had a slight enhancing effect compared to untreated cells. The underlying reason for this effect is unknown, but we have observed this effect also with the other RGD-modified Ads and also the control AdZ (data not shown). All the other RGDmodified vectors (AdD, AdF, AdG, AdH and AdI) only marginally increased the eGFP expression levels as compared to AdZ or had even slightly lower efficiencies than AdZ (Figure 2a-d) . The low levels of transductions were not inhibited by soluble RGD peptides, except for AdI, where RGD peptides resulted in 35% inhibition (not shown).
It is well known that most hematopoietic cells are largely resistant to species C Ad infections due to lack of CAR and appropriate integrins. 23, 24, 32 Our results of RGD-4C Ad transduction of CAR-less Daudi lymphoma cells and hematopoietic U937 H cells were in agreement with this notion, and the absolute eGFP expression levels were even a few fold lower than with the CARless nonhematopoietic melanoma cells and fibroblasts. The eGFP expression in Daudi cells increased 76-and 313-fold when using RGD-4C AdE and AdK, respectively, whereas for U937 H cells, expression was augmented by 38-and 150-fold, respectively ( Figure  4 ). All the other mutants including AdCMV-eGFP-I, demonstrated only a low increase, maximally 2.3-fold. However, in contrast to nonhematopoietic cells, the high AdE-and AdK-mediated transduction of Daudi and U937 H cells did not correlate with the levels of avb5 integrin (Table 4) , implicating additional 
Integrin targets of RGD-4C fiber-modified adenoviruses
H Nagel et al RGD-binding receptors. Otherwise, despite the expression of avb3 integrin in mature (day 10) monocyte derived DCs, such cells remained highly resistant to all of our RGD-Ads. The latter result was, however, different from another study, 53 which found an enhanced transduction of DCs by RGD-4C Ad, but was also using a different protocol, including a different cytokine mix and different timing to generate the DCs. This is known to crucially affect the differentiation of DCs. 54 Further, the THP-1, HL-60 or U937D hematopoietic cells lacking both CAR and most av integrins (see Table 4 , and Huang et al It is interesting to note that the AdK was slightly more potent than AdE (two-to three-fold) in all the CARless av integrin-positive cells that we have tested. This may suggest that the inserted RGD motif of AdK could be better accessible for integrin interactions than the RGD motif of AdE replacing parts of the HI loop. Taken together, all the five CAR-negative adherent cells and two nonadherent hematopoietic cells were efficiently and specifically transduced with the RGD-4C containing AdE and AdK. However, five-to 10-fold higher amounts of AdE and AdK were necessary to get transgene expressions comparable to CAR-expressing cells (for comparison see Figures 1a and 2b) . This suggests that CAR targeting is more efficient than targeting RGD receptors, which was confirmed by the observations that the RGD-Ads did not increase the transduction of CAR-positive cells, in agreement with published data. 57 
RGD-4C Ad specifically targets the avb5 integrin of CAR-negative cells
Integrins are major receptors of RGD-based ligands. 10 We therefore analyzed the binding of radiolabelled RGD-4C AdE, RGD-4C AdK and wt fiber AdZ to CAR-positive cells and to CAR-negative melanoma and lymphoma cells in the presence and absence of soluble RGDcompetitor peptide and adhesion-blocking anti-integrin antibodies. The optimal concentrations of these inhibitors were previously determined by dose-escalation experiments (results not shown) and used as indicated in Materials and methods. Upon cold incubation (to prevent virus internalization), about 3% of the [35] -S Integrin targets of RGD-4C fiber-modified adenoviruses H Nagel et al methionine-labelled AdE, AdK or AdZ bound specifically to A549 cells positive for CAR and avb5. This binding was in the very same range as determined previously with wt Ad2 to HeLa cells. 58 It was largely blocked by the soluble CARex-Fc protein which has earlier been shown to inhibit virus binding to cell surface CAR 45 but not by control CTLA4-Ig protein (not shown). In contrast, soluble RGD peptides or anti-integrin antibodies (see Table 2 ) had no effect on AdK binding (not shown), confirming the dominant role of CAR over integrins in epithelial target cells.
With the CAR-negative primary melanoma cultures M950504, M960104, M961205 and M950710, 33 between 0.7 and 2.5% of the input AdE and AdK was cell-bound, whereas less than 0.07% of the input AdZ control virus bound to these cells. Binding of AdK (but not AdZ) to M950504 and M950710 melanoma cells was strongly blocked by soluble RGD peptides (94% inhibition) or soluble CARex-Fc (93% inhibition, see Figure 5a and b), whereas irrelevant glutathion peptide and CTLA4-Ig protein had no effect, indicating that AdK attached to cells via its constrained RGD-4C of the fiber knob domain. We next employed function-blocking antiintegrin antibodies to discern if AdK bound to surface integrins. The anti-avb5 and the anti-av antibodies P1F6 59 and 17E6 60 reduced virus binding in the cold by about 80% and the non-function-blocking anti-b5 antibody B5-IA9 61 had the same effect (Figure 5a ). Importantly, function-blocking anti-avb3, 62 b1, a5, a6 or aIIbb3 antibodies did not affect AdK binding to M950504 cells, although these cells expressed significant amounts of b1 and a5 integrins and low but detectable amounts of avb3, a6 and aIIbb3 integrins (Table 3) . We obtained the same results also with the M960104 and M961205 cells, which expressed slightly higher amounts of the same integrins as the M950504 cells (not shown). In contrast, the melanoma culture M950710 expressing very low levels of avb3 and avb5 integrins was resistant to all the antibodies, including an irrelevant control antibody E12/ 4, that we have tested in AdK-binding assays (Figure 5b) .
We further tested the binding of AdE and AdK to the CAR-negative, weakly avb5-positive Daudi and U937 H cells and obtained significant binding in the range of 0.7-1.1%. Binding of control AdZ was insignificant (o0.007%). AdK binding was effectively inhibited by soluble RGD or CARex-Fc peptides but none of the antiintegrin antibodies, including avb3 specific antibodies, affected AdK binding (Figure 6 ), although avb3 integrin was abundantly present on Daudi cells (Table 4 ). This suggests that in the absence of avb5 integrin, yet other RGD-binding cell surface receptors can be targeted by the constrained RGD-4C of AdK, but these targets are unlikely to comprise the avb3 integrin or other RGDbinding integrins composed of either av, a5, a6, b1, b3 and b5 subunits.
Discussion
A variety of genetic modifications of Ad capsid proteins have retargeted Ad vectors to cells of interest and thus enhanced the transduction of a number of CAR-deficient cell types in vitro, including primary human fibroblasts, 63 endothelial cells, 41, 63 smooth muscle cells, 42, 63 glioblastoma, 63 macrophages and T cells, 40 acute myeloid leukaemic cells, 64 myeloma cells 65 and ovarian cancer cells. 41 In some cases, vector binding could be uncoupled from internalization, but internalization itself is often crucially linked to cell activation and subsequent steps of entry, such as endosome escape and nuclear targeting (reviewed in Greber 6 ). The receptor responsible for stimulating endocytosis of species C Ad vectors has been identified as avb3 and avb5 integrins. 5 Subsequently, additional a5b1 and avb1 integrin coreceptors were found. 11, 13 These integrins activate the target cell upon binding the RGD motif of the capsid protein penton base. In the case of avb5, this appears to require a precise Integrin targets of RGD-4C fiber-modified adenoviruses H Nagel et al spatial arrangement of the integrins. 43 Since the affinity of penton base to avb3 and avb5 integrins is rather low (in the range of hundred nanomolar 5 ), the primary receptor CAR is crucial for infection. 3 Accordingly, CARdeficient cells are generally refractory to infection and transduction with therapeutic Ad vectors.
Here we generated and tested a series of seven fiber HI-loop-modified Ads in order to directly target integrins. The HI loop of the fiber knob was chosen as an engineering site, since it is exposed towards the outside and not directly involved in homotypic fiber contacts and CAR binding. [66] [67] [68] Of the seven RGD-fiber-modified Ads that we have generated here, only the RGD-4C Ads (designated here AdE and AdK) and to a lower extent AdI, harboring three simple RGD motifs, were able to enhance transduction in an RGD-dependent manner. The better performance of the RGD-4C Ads was most likely because of the disulfide-constrained configuration of this high-affinity peptide. Three different versions of RGD motifs were reported in the literature to be successfully integrated into Ad fiber and enhance transduction. These included the above-mentioned RGD-4C nonapeptide, which was either incorporated into the fiber HI loop 41 or into the fiber C-terminus, 40 a linear tripeptide RGD incorporated in the C terminus of a deknobbed fiber consisting of seven shaft repeats followed by a heterologous trimerization motif and a spacer sequence, 69 and the RGD motif of penton base incorporated into the HIloop together with flanking sequences on both sides. 70 Using the same penton base RGD motif in combination with short flanking sequences, we could not detect any significant improvement of gene transfer with the AdD. Only a few fold enhancements 70 were reported when using more extended flanking sequences. Similarly, another RGD motif, (GRGDTF) 3 , was introduced at the C terminus of the fiber but did not increase the delivery to integrin-expressing cells relative to an unmodified vector, 40 in agreement with our results. Together, these data show that a linear or little constrained RGD may not adopt the optimal conformation to activate integrins. In addition, our data show that a replacement of the HI loop with the RGD-4C motif is feasible although it weakly decreased the transduction efficiency compared to the inserted RGD-4C version. It is possible that flanking sequences are important to enhance the exposure of peptide motifs integrated in the HI loop and that for each type of targeting peptide, an individual flanking sequence is required for optimal interactions with the target receptor.
Using function-blocking antibodies and quantitative virus-binding experiments together with transduction experiments in a variety of CAR-deficient cells, we demonstrate that only the RGD-4C Ads are truly targeted to cell surface integrins. The transduction experiments were conducted with two types of CAR-negative cells, nonhematopoietic and hematopoietic cells. The transductions of the CAR-negative primary melanoma cell cultures M950504, M961205 and M960104 with AdK indicated an important role of avb5 integrins. However, in cells with very low levels of avb5, for example in M950710, Daudi or U937H lymphoma cells, binding of the RGD-4C Ad was not inhibited by anti-avb5 integrin antibodies but it was still sensitive towards soluble RGDpeptide competitor, indicating that additional RGDbinding receptors on these cells can serve as an Ad transduction receptor. Based on our experiments involving the two function-blocking anti-integrin antibodies for av and avb3, we are suggesting that avb3 integrin is not involved in the transduction mechanism of RGD-4C Ads. That the RGD-4C Ads did not bind avb3 integrin is somewhat surprising, since it was originally demonstrated to have high affinity to avb3 and avb5 integrins using phage display screens. 39 Likewise, recombinant extracellular domains of avb3 bound to immobilized RGD-4C-modified fibers or to whole RGD-4C Ad in vitro. 41 It is possible that our RGD-4C Ads fail to bind the cell-associated avb3 integrin because the constrained RGD conformation is different from the soluble RGD peptide and because the full-length transmembrane integrins have a narrower binding specificity than the soluble domains. Accordingly, our results agree with a recent study showing that, preferentially, avb3-binding peptides do not compete with the RGD-4C Ad. 71 Alternatively, it is possible that on the cells that we have tested here, the avb3 integrin lacks a particular cofactor that renders it competent for binding the RGD-modified Ads. Based on the results using one function-blocking integrin antibody each for a5, b1, a6, aIIbb3, we suggest that these integrin subunits do not serve as efficient RGD-4C targets. However, use of additional integrin antibodies are warranted to confirm these findings. Furthermore, it remains to be tested whether non-RGDbinding integrins, such as amb2 (CD11b), aLb2 (CD11a) and aXb2 (CD11c) 55 are responsible for the tropism of RGD-4C Ads or if even nonintegrin receptors are involved.
Our results support the notion that the RGD-4C fiber HI loop-modified Ad vectors specifically target the avb5 integrin, but that also additional, so far undefined integrins, are likely to be targeted by these vectors. Although these results add further weight to the proposal that RGD-modified Ads may be locally administered for cancer therapies, targeting for example CARnegative ovarian cancer, 72 we must add a note of caution. Given the residual strong CAR binding of the RGD-4C Ad vectors (see also Gipe et al
57
) and also the expanded tropism, extreme care should be taken before using these vectors in human therapies. In particular, not all the RGD targets of this virus are fully characterized, raising the concern of unwanted transduction events. Indeed, when Mizugucchi et al analysed their RGD-4C Ad, they detected a so far unrecognized hemagglutination activity of mouse erythrocytes, 73 which may be responsible for the reduced transduction of liver cells when using this virus in systemic administrations. Although this agglutination activity was not found with human erythrocytes, these results illustrate that we do not fully comprehend the underlying events of systemic Ad transductions. The RGD-4C-modified Ads described here have a significant potential to transduce CAR-less hematopoietic and also nonhematopoietic cells, but their preferred use may be together with additional strategies, such as transcriptional restrictions and selective deletions of viral genes and CAR-binding ablations of the fiber knob.
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